Clinical Trial Update: Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating RT001 for efficacy and safety in adults with moderate to severe lateral canthal lines (crow's feet/facial wrinkles) has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crow Feet
• Facial Wrinkles
• Lateral Canthal Lines

Drugs mentioned

• RT001

Snippet

Sponsor: Revance Therapeutics, Inc. | Conditions: Lateral Canthal Lines, Crow's Feet | Phase 2 | Status: COMPLETED